Entrada Therapeutics, Inc. (TRDA)

NASDAQ: TRDA · Real-Time Price · USD

6.71

+0.07 (1.05%)

At close: Sep 22, 2026, 4:00 PM EDT

6.71

0.00 (0.00%)

After-hours: Sep 22, 2026, 4:54 PM EDT

Entrada Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	242	369	612	503	424	534
Market Cap Growth	25.56%	-39.78%	21.70%	18.72%	-20.71%	-
Enterprise Value	67	94	224	219	236	610
Last Close Price	6.64	10.28	17.29	15.09	13.52	17.12

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	9.33	-	-	-
PS Ratio	51.78	14.50	2.90	3.90	-	-
PB Ratio	1.03	1.20	1.43	2.08	1.99	1.79
P/TBV Ratio	1.04	1.20	1.43	2.08	1.99	1.79
P/FCF Ratio	-	-	-	3.75	-	-
P/OCF Ratio	-	-	-	3.60	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	14.55	3.71	1.06	1.69	-	-
EV/EBITDA Ratio	-	-	4.41	-	-	-
EV/EBIT Ratio	-	-	4.77	-	-	-
EV/FCF Ratio	-	-	-	1.63	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.21	0.17	0.14	0.28	0.12	-
Debt / EBITDA Ratio	-	-	0.92	4.68	-	-
Debt / FCF Ratio	-	-	-	0.51	-	-
Net Debt / Equity Ratio	-0.75	-0.80	-0.84	-1.17	-0.77	-0.97
Net Debt / EBITDA Ratio	1.02	1.61	-7.10	883.92	1.71	5.82
Net Debt / FCF Ratio	1.30	1.89	8.07	-2.11	1.68	5.25
Asset Turnover	0.01	0.06	0.42	0.36	-	-
Quick Ratio	10.52	12.20	10.78	2.26	8.62	43.32
Current Ratio	10.89	12.53	11.15	2.33	9.55	44.46
Return on Equity (ROE)	-54.10%	-39.13%	19.56%	-2.94%	-37.01%	-30.19%
Return on Assets (ROA)	-29.20%	-21.58%	5.90%	-0.55%	-21.79%	-18.29%
Return on Invested Capital (ROIC)	-280.08%	-241.38%	350.11%	41.75%	-338.65%	-1165.02%
Return on Capital Employed (ROCE)	-62.90%	-44.20%	9.70%	-1.00%	-42.30%	-17.10%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-68.32%	-38.99%	10.72%	-1.33%	-22.33%	-9.57%
FCF Yield	-55.37%	-35.14%	-7.30%	26.68%	-22.82%	-10.38%
Buyback Yield / Dilution	-1.93%	-6.07%	-18.01%	-5.62%	-399.27%	-467.09%

SEC Filings: 10-K · 10-Q